Cancer‐Targeting Peptides Functionalized With Polyarginine Enables GRP78‐Dependent Cell Uptake and siRNA Delivery Within the DU145 Prostate Cancer Cells
Journal of Peptide Science · 2025
DOI: 10.1002/psc.70007 ↗At a glance
Journal article in Journal of Peptide Science, 2025. Written by George Hilan and 4 co-authors. Institution: Department of Biology, Carleton University, Ottawa, ON, Canada. Major MEDLINE topics: RNA, Small Interfering, Prostatic Neoplasms, Peptides, Heat-Shock Proteins. Cited 6 times so far (Crossref); 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation.
Abstract (original language)
This study investigated a peptide‐based GRP78‐targeting strategy for short‐interfering (si) RNA delivery in cancer cells. Synthetic fluorescein‐labeled amphiphilic peptides composed of the hydrophobic cell surface (cs) GRP78‐targeting and hydrophilic, polycationic arginine‐rich cell penetrating peptides demonstrated GRP78‐dependent cell uptake in the DU145 prostate cancer cells, and to a lesser extent in the non‐cancerous human lung fibroblast WI‐38 cell line. Mechanistic studies revealed energy‐dependent GRP78 receptor‐mediated endocytosis of the GRP78‐targeting peptide with polyarginine (W1‐R9). The cytosolic accumulation of this peptide underscored its potential utility in siRNA delivery. Peptide:siRNA complexes formed stably condensed nanoparticles, with calcium functioning as an ionic stabilizer and additive promoting endosomal siRNA escape for RNA interference (RNAi) activity. Preliminary peptide‐based siRNA transfections in the DU145 cells demonstrated that GRP78 knockdown led to an interplay in between pro‐survival and cell death outcomes under ER stress induction. Thus, the GRP78‐targeting polyarginine peptides enables efficient cell uptake for specific siRNA delivery in the DU145 cells. This class of bio‐active synthetic peptides is important for the investigation of cancer biology, leading to the innovation of cancer‐targeted gene delivery and therapy approaches.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biology, Carleton University, Ottawa, ON, Canada.
- Department of Chemistry, Carleton University, Ottawa, ON, Canada.
- Institute of Biochemistry, Carleton University, Ottawa, ON, Canada.
ORCID profiles: David Sabatino
Funding
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
Cite
APA
Hilan, G., Daniel, G., Collak, F., Sabatino, D., & Willmore, W. G. (2025). Cancer‐Targeting Peptides Functionalized With Polyarginine Enables GRP78‐Dependent Cell Uptake and siRNA Delivery Within the DU145 Prostate Cancer Cells. Journal of Peptide Science. https://doi.org/10.1002/psc.70007
Vancouver
Hilan G, Daniel G, Collak F, Sabatino D, Willmore WG. Cancer‐Targeting Peptides Functionalized With Polyarginine Enables GRP78‐Dependent Cell Uptake and siRNA Delivery Within the DU145 Prostate Cancer Cells. Journal of Peptide Science. 2025. doi:10.1002/psc.70007
BibTeX
@article{Hilan2025,
author = {Hilan, George and Daniel, Grace and Collak, Filiz and Sabatino, David and Willmore, William G},
title = {Cancer‐Targeting Peptides Functionalized With Polyarginine Enables GRP78‐Dependent Cell Uptake and siRNA Delivery Within the DU145 Prostate Cancer Cells},
journal = {Journal of Peptide Science},
year = {2025},
doi = {10.1002/psc.70007}
}
EUVIMED